These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 29166502)

  • 1. Outcomes of long term treatments of type I hereditary angioedema in a Turkish family.
    Akoglu G; Kesim B; Yildiz G; Metin A
    An Bras Dermatol; 2017; 92(5):655-660. PubMed ID: 29166502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis.
    Kreuz W; Martinez-Saguer I; Aygören-Pürsün E; Rusicke E; Heller C; Klingebiel T
    Transfusion; 2009 Sep; 49(9):1987-95. PubMed ID: 19497056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions for the long-term prevention of hereditary angioedema attacks.
    Beard N; Frese M; Smertina E; Mere P; Katelaris C; Mills K
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013403. PubMed ID: 36326435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary angioedema with normal c1 inhibition.
    Bork K
    Curr Allergy Asthma Rep; 2009 Jul; 9(4):280-5. PubMed ID: 19656474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of danazol treatment on growth in pediatric patients with hereditary angioedema due to C1-inhibitor deficiency].
    Kőhalmi KV; Veszeli N; Luczay A; Varga L; Farkas H
    Orv Hetil; 2017 Aug; 158(32):1269-1276. PubMed ID: 28780879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow-mediated vasodilation assay indicates no endothelial dysfunction in hereditary angioedema patients with C1-inhibitor deficiency.
    Nebenführer Z; Szabó E; Kajdácsi E; Kőhalmi KV; Karádi I; Zsáry A; Farkas H; Cervenak L
    Ann Allergy Asthma Immunol; 2019 Jan; 122(1):86-92. PubMed ID: 30312677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary angioedema due to C1-inhibitor deficiency in Macedonia: clinical characteristics, novel SERPING1 mutations and genetic factors modifying the clinical phenotype.
    Grivčeva-Panovska V; Košnik M; Korošec P; Andrejević S; Karadža-Lapić L; Rijavec M
    Ann Med; 2018 May; 50(3):269-276. PubMed ID: 29513108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of long-term danazol treatment on haematological parameters in hereditary angioedema.
    Kőhalmi KV; Veszeli N; Zotter Z; Csuka D; Benedek S; Imreh É; Varga L; Farkas H
    Orphanet J Rare Dis; 2016 Feb; 11():18. PubMed ID: 26911866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary Angioedema: Diagnosis, Clinical Implications, and Pathophysiology.
    Sinnathamby ES; Issa PP; Roberts L; Norwood H; Malone K; Vemulapalli H; Ahmadzadeh S; Cornett EM; Shekoohi S; Kaye AD
    Adv Ther; 2023 Mar; 40(3):814-827. PubMed ID: 36609679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parameters of the classical complement pathway predict disease severity in hereditary angioedema.
    Csuka D; Füst G; Farkas H; Varga L
    Clin Immunol; 2011 Apr; 139(1):85-93. PubMed ID: 21300570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular diagnosis and management of hereditary angioedema in a Greek family.
    Papadopoulou-Alataki E; Foerster T; Antari V; Pavlitou-Tsiontsi A; Varlamis G
    Int Arch Allergy Immunol; 2008; 147(2):166-70. PubMed ID: 18535392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent attacks of hereditary angioedema: a case of delayed diagnosis.
    Jacobs J
    Allergy Asthma Proc; 2011; 32 Suppl 1():23-26. PubMed ID: 22195758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Hereditary Angioedema.
    Caballero T
    J Investig Allergol Clin Immunol; 2021 Feb; 31(1):1-16. PubMed ID: 33602658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human C1 esterase inhibitor in the management of hereditary angioedema.
    Riedl M
    Clin Drug Investig; 2015 Jul; 35(7):407-17. PubMed ID: 26091744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical manifestations, diagnosis, and treatment of hereditary angioedema: survey data from 94 physicians in Japan.
    Ohsawa I; Honda D; Nagamachi S; Hisada A; Shimamoto M; Inoshita H; Mano S; Tomino Y
    Ann Allergy Asthma Immunol; 2015 Jun; 114(6):492-8. PubMed ID: 25872948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients.
    Bork K; Bygum A; Hardt J
    Ann Allergy Asthma Immunol; 2008 Feb; 100(2):153-61. PubMed ID: 18320917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human C1 esterase inhibitor for the treatment of hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE).
    Sabharwal G; Craig T
    Expert Rev Clin Immunol; 2015 Mar; 11(3):319-27. PubMed ID: 25669442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Migraine-like headache in a patient with complement 1 inhibitor deficient hereditary angioedema.
    Chung JY; Kim M
    J Korean Med Sci; 2012 Jan; 27(1):104-6. PubMed ID: 22219624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Hereditary Angioedema Attacks with Icatibant and Recombinant C1 Inhibitor During Pregnancy.
    Hakl R; Kuklínek P; Krčmová I; Králíčková P; Freiberger T; Janků P; Vlková M; Litzman J
    J Clin Immunol; 2018 Oct; 38(7):810-815. PubMed ID: 30280305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis, Course, and Management of Angioedema in Patients With Acquired C1-Inhibitor Deficiency.
    Zanichelli A; Azin GM; Wu MA; Suffritti C; Maggioni L; Caccia S; Perego F; Vacchini R; Cicardi M
    J Allergy Clin Immunol Pract; 2017; 5(5):1307-1313. PubMed ID: 28284781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.